Aflac Incorporated (AFL) Operating Cash Flow CAGR:N/A(TTM)
The operating cash flow cagr for Aflac Incorporated (AFL) is N/A over the latest trailing 12-month period. Operating cash flow CAGR uses precomputed cash-flow statement history (cash from operations, before capital expenditures).
The operating cash flow cagr for Aflac Incorporated (AFL) stock is N/A over the past 12 months. The 3 year average growth rate is -5.79% and the 5 year cagr is -13.07%. Operating cash flow CAGR measures the compound annual growth rate of the cash Aflac Incorporated generates from its core business operations, before capital expenditures, computed from rolling-twelve-month cash-flow statement history. The 1-year (TTM) figure is omitted: a one-year rate off a single quarter's base is volatile; the multi-year figures are the reliable read.
AFL Operating Cash Flow CAGR Chart
Aflac Incorporated (AFL)
AFL Operating Cash Flow CAGR History
| Year | Start OCF | End OCF | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $2.71B | $2.56B | $-152.00M | -5.62% | -5.62% |
| 2024 | $3.19B | $2.71B | $-483.00M | -15.14% | -15.14% |
| 2023 | $3.88B | $3.19B | $-689.00M | -17.76% | -17.76% |
| 2022 | $5.05B | $3.88B | $-1.17B | -23.20% | -23.20% |
| 2021 | $5.96B | $5.05B | $-907.00M | -15.22% | -15.22% |
| 2020 | $5.46B | $5.96B | +$503.00M | +9.22% | +9.22% |
| 2019 | $6.01B | $5.46B | $-559.00M | -9.29% | -9.29% |
| 2018 | $6.13B | $6.01B | $-114.00M | -1.86% | -1.86% |
| 2017 | $5.99B | $6.13B | +$141.00M | +2.36% | +2.36% |
| 2016 | $6.78B | $5.99B | $-789.00M | -11.64% | -11.64% |
| 2015 | $6.55B | $6.78B | +$226.00M | +3.45% | +3.45% |
| 2014 | $10.55B | $6.55B | $-4.00B | -37.90% | -37.90% |
| 2013 | $14.95B | $10.55B | $-4.41B | -29.46% | -29.46% |
| 2012 | $10.84B | $14.95B | +$4.11B | +37.91% | +37.91% |
| 2011 | $6.99B | $10.84B | +$3.85B | +55.13% | +55.13% |
| 2010 | $6.16B | $6.99B | +$828.00M | +13.44% | +13.44% |
| 2009 | $4.96B | $6.16B | +$1.20B | +24.09% | +24.09% |
| 2008 | $4.66B | $4.96B | +$309.00M | +6.64% | +6.64% |
| 2007 | $4.40B | $4.66B | +$259.00M | +5.89% | +5.89% |
| 2006 | $4.43B | $4.40B | $-36.00M | -0.81% | -0.81% |
| 2005 | $4.49B | $4.43B | $-53.00M | -1.18% | -1.18% |
| 2004 | $3.39B | $4.49B | +$1.10B | +32.37% | +32.37% |
| 2003 | $3.04B | $3.39B | +$351.00M | +11.55% | +11.55% |
| 2002 | $2.85B | $3.04B | +$189.00M | +6.63% | +6.63% |
| 2001 | $3.25B | $2.85B | $-396.00M | -12.20% | -12.20% |
| 2000 | $2.81B | $3.25B | +$438.00M | +15.60% | +15.60% |
| 1999 | $2.50B | $2.81B | +$307.00M | +12.28% | +12.28% |
| 1998 | $2.60B | $2.50B | $-98.00M | -3.77% | -3.77% |
| 1997 | $2.69B | $2.60B | $-96.00M | -3.56% | -3.56% |
About Aflac Incorporated
Aflac Incorporated, operating through its various subsidiary companies, focuses on delivering supplementary health and life insurance policies. The firm's business activities are structured into two primary divisions: Aflac Japan and Aflac U.S. In Japan, the company offers a diverse range of insurance products, including coverage for cancer, medical expenses, income support for nursing care, and the distinct GIFT plan. This segment also provides traditional whole and term life insurance, along with savings-oriented plans like WAYS and child endowment products. Meanwhile, the Aflac U.S. division caters to the American market, furnishing policies that address cancer, accidents, short-term disability, critical illness, and hospital stays. Additionally, it provides dental, vision, long-term care, disability, and both term and whole life insurance options. Aflac distributes its comprehensive suite of products through multiple channels, which include dedicated sales associates, independent brokers, various corporate and individual agencies, and affiliated agencies. Established in 1955, the company maintains its corporate headquarters in Columbus, Georgia.
- Sector
- Financial Services
- Industry
- Insurance - Life
- CEO
- Daniel Paul Amos